# Bisoprolol Fumarate and Hydrochlorothiazide

NDC: 10135-741
Generic name: Bisoprolol Fumarate and Hydrochlorothiazide
Labeler / Manufacturer: Marlex Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20220501

FDA application: ANDA215562

## Active ingredients

- BISOPROLOL FUMARATE: 5 mg/1
- HYDROCHLOROTHIAZIDE: 6.25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10135-741"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10135-741
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=df881501-42ae-624a-e053-2995a90ab2a0
